• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

National Institutes of Health (NIH)

Quidel wins FDA nod for at-home antigen test

March 1, 2021 By Nancy Crotti Leave a Comment

The FDA issued an emergency use authorization today for the Quidel Corp. (NSDW:QDEL) QuickVue At-Home COVID-19 test, another antigen test to rapidly collect and test samples at home, without the need to send a sample to a laboratory for analysis. The QuickVue At-Home COVID-19 test is authorized for prescription home use with self-collected nasal swab […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Abbott, antigen test, CareEvolution, coronavirus, COVID-19, Ellume, National Institutes of Health (NIH), Quidel Corp.

NIH increases PhysIQ contract to $6.6M

January 19, 2021 By Sean Whooley

PhysIQ announced today that the National Institutes of Health (NIH) entered into Phase II of a contract for its AI-based COVID-19 biomarker. A Purdue University-affiliated artificial intelligence company, PhysIQ’s AI-based COVID-19 digital biomarker is being developed to address the rapid decompensation of high-risk COVID-19 patients, according to a news release. PhysIQ’s technology’s cloud platform continuously […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Funding Roundup, Health Technology, Patient Monitoring, Software / IT Tagged With: coronavirus, COVID-19, national cancer institute, National Institutes of Health (NIH), physiq

Spark Biomedical wins FDA breakthrough nod for newborn opioid withdrawal relief device

December 16, 2020 By Nancy Crotti

Spark Biomedical announced today that the FDA granted breakthrough device designation to its transcutaneous electrical nerve stimulator designed to reduce signs and symptoms of neonatal opioid withdrawal syndrome (NOWS). NOWS results from exposure to prescription or non-prescription opioids such as methadone or heroin during pregnancy. Currently, no nationwide standard of care exists for managing NOWS, although […]

Filed Under: Bioelectronic Medicine, Featured, Food & Drug Administration (FDA), Hospital Care, Neuromodulation/Neurostimulation, Pediatrics, Regulatory/Compliance Tagged With: FDA, National Institutes of Health (NIH), opioid crisis, Spark Biomedical

Study: ECMO ‘significantly’ improves heart attack patients’ survival

November 13, 2020 By Sean Whooley

The National Institutes of Health (NIH) is touting a study that found the use of life support improved survival in certain cardiac arrest patients. Published in The Lancet, the study, known as the Advanced Reperfusion Strategies for Refractory Cardiac Arrest (ARREST) trial, used the life support machine called extracorporeal membrane oxygenation ECMO to replicate the […]

Filed Under: Cardiovascular, Clinical Trials, Featured Tagged With: Abiomed, and Blood Institute NHLBI, coronavirus, COVID-19, LivaNova, Medtronic, National Institutes of Health (NIH)

NIAID halts Lilly COVID-19 antibody study

October 27, 2020 By Nancy Crotti

An arm of NIH has ended a clinical trial investigating the use of Eli Lilly’s (NYSE:LLY) monoclonal antibody LY-CoV555 (bamlanivimab) to treat hospitalized COVID-19 patients. While the drug shows promise in treating mild-to-moderate COVID-19 infections, the ACTIV-3 trial involving severe cases of the disease showed little benefit, according to the National Institute of Allergy and Infectious Diseases […]

Filed Under: Business/Financial News, Clinical Trials Tagged With: coronavirus, COVID-19, Eli Lilly & Co., National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

Minnetronix lands NIH grant to study spinal fluid treatment tech

October 20, 2020 By Nancy Crotti

Minnetronix Medical today announced that it has been awarded a National Institutes of Health (NIH) grant for continued study of its proprietary Neurapheresis cerebrospinal fluid treatment platform. Akin to hemodialysis, the Neurapheresis platform is designed to rapidly remove blood cells and their cytotoxic byproducts that are released into cerebrospinal fluid following an aneurysmal subarachnoid hemorrhage. Get […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Funding Roundup, Neurological, Research & Development Tagged With: Minnetronix Medical, National Institutes of Health (NIH)

NIH launches drug trial for deadly cytokine storm

October 16, 2020 By Sean Whooley

The National Institutes of Health today launched a Phase 3 clinical trial to evaluate three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which the immune system unleashes proteins that trigger inflammation, otherwise known as a cytokine storm, which can lead to acute respiratory distress syndrome, multiple […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical Tagged With: AbbVie, Bristol-Myers Squibb Co., coronavirus, COVID-19, Janssen Pharmaceuticals, Johnson & Johnson, National Institutes of Health (NIH)

What are the top COVID-19 vaccine candidates?

September 25, 2020 By Nancy Crotti

As of yesterday, five COVID-19 vaccine candidates had begun Phase 3 clinical trials as they seek to determine the safety and efficacy of their formulas. Researchers worldwide are testing 132 COVID-19 vaccine candidates, including 42 that are in clinical trials on humans and at least 92 in preclinical or animal trials, according to the New […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, BioNTech, coronavirus, COVID-19, GlaxoSmithKline plc, Johnson & Johnson, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Pfizer, Sanofi, U.S. Biomedical Advanced Research and Development Authority (BARDA)

J&J launches fourth large-scale COVID-19 vaccine trial

September 23, 2020 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) has begun enrollment of adult volunteers for a fourth Phase 3 clinical trial of a COVID-19 vaccine candidate. The National Institutes of Health announced today that J&J’s Janssen Pharmaceuticals COVID-19 vaccine candidate (JNJ-78436725) has begun the Phase 3 trial to evaluate if it can prevent symptomatic COVID-19 after a single dose regimen. Up […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Janssen Pharmaceuticals, Johnson and Johnson, National Institutes of Health (NIH), U.S. Biomedical Advanced Research and Development Authority (BARDA)

iotaMotion lands $1.65M NIH grant to develop robotic cochlear implant tech

September 10, 2020 By Sean Whooley

Robotic surgical technology developer iotaMotion announced that it received a $1.65 million grant from the National Institutes of Health (NIH). Iowa City, Iowa-based iotaMotion said in a news release that it is using the grant funds to continue developing its real-time tissue trauma sensing technology in the iotaSoft robotic surgical system designed for assistance in […]

Filed Under: Business/Financial News, Funding Roundup, Robotics, Surgical Tagged With: iotamotion, National Institutes of Health (NIH), NIH

NIH to boost COVID-19 testing capabilities

September 3, 2020 By Sean Whooley

The National Institutes of Health announced a $129.3 million plan to support scaling and manufacturing for COVID-19 tests. As part of its Rapid Acceleration of Diagnostics (RADx) initiative, NIH is awarding contracts to nine companies for their technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can produce results in 24 […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics Tagged With: Aegis Sciences, Broad Institute, Ceres Nanoscience, coronavirus, COVID-19, Illumina Inc., MatMaCorp, Maxim Biomedical, MicroGEM International, National Institutes of Health (NIH), NIH, PathGroup, Sonic Healthcare USA

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS